Cost of illness of cystic fibrosis in Germany: results from a large cystic fibrosis centre.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2012 AND VI 30 AND IP 9
Results: 14
1
2
Reimbursement decisions of the All Wales Medicines Strategy Group: influence of policy and clinical and economic factors.
- Published in:
- 2012
- By:
- Publication type:
- journal article
3
Assessing the quality of pharmacoeconomic studies in India: a systematic review.
- Published in:
- 2012
- By:
- Publication type:
- journal article
4
Lost productivity in four European countries among patients with rheumatic disorders: are absenteeism and presenteeism transferable?
- Published in:
- 2012
- By:
- Publication type:
- journal article
5
Dabigatran etexilate: a pharmacoeconomic review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.
- Published in:
- 2012
- By:
- Publication type:
- journal article
6
The Authors' Reply.
- Published in:
- 2012
- By:
- Publication type:
- Letter
7
Caregivers' Quality of Life and Economic Evaluations.
- Published in:
- 2012
- By:
- Publication type:
- Letter
8
Dabigatran Etexilate A Pharmacoeconomic Review of its Use in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 9, p. 841, doi. 10.2165/11209130-000000000-00000
- By:
- Publication type:
- Article
9
A Lifetime Markov Model for the Economic Evaluation of Chronic Obstructive Pulmonary Disease.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 9, p. 825, doi. 10.2165/11591340-000000000-00000
- By:
- Publication type:
- Article
10
Costs Associated with Febrile Neutropenia in the US.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 9, p. 809, doi. 10.2165/11592980-000000000-00000
- By:
- Publication type:
- Article
11
Reimbursement Decisions of the All Wales Medicines Strategy Group Influence of Policy and Clinical and Economic Factors.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 9, p. 779, doi. 10.2165/11591530-000000000-00000
- By:
- Publication type:
- Article
12
Cost of Illness of Cystic Fibrosis in Germany Results from a Large Cystic Fibrosis Centre.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 9, p. 763, doi. 10.2165/11588870-000000000-00000
- By:
- Publication type:
- Article
13
Assessing the Quality of Pharmacoeconomic Studies in India A Systematic Review.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 9, p. 749, doi. 10.2165/11590140-000000000-00000
- By:
- Publication type:
- Article
14
Lost Productivity in Four European Countries among Patients with Rheumatic Disorders Are Absenteeism and Presenteeism Transferable?
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 9, p. 795, doi. 10.2165/11591520-000000000-00000
- By:
- Publication type:
- Article